Clinical trial
Indicated Prevention of Psychotic Disorders With Low-dose Lithium
NCT00202306 · Melbourne Health, Other · Completed
Key facts
| NCT number | NCT00202306 |
|---|---|
| Title | Indicated Prevention of Psychotic Disorders With Low-dose Lithium |
| Official title | An Open-labeled, Parallel-group, Single-blinded (Rater) Pilot Study to Investigate the Neuroprotective Effects of of Low-dose Lithium in Young Subjects at Ultra High Risk (UHR) of Developing a First-episode Psychotic Disorder |
| Lead sponsor | Melbourne Health, Other |
| Collaborators | National Institute of Mental Health (NIMH) NIH |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Schizophrenia, Bipolar Disorder, Psychotic Disorders |
| Intervention type | Drug |
| Interventions | lithium carbonate |
| Enrollment | 30 |
| Start date | Nov 1, 2001 |
| Primary completion | Dec 1, 2006 |
| Completion | Dec 1, 2006 |
| First posted | Sep 20, 2005 |
| Last update posted | May 30, 2013 |
| Countries | Australia |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: